Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2005

View Archived Issues

Topical treatment with the novel thiazolidinedione BP-1107 reduces epidermal hyperplasia

Patients with chronic primary insomnia improve after eszopiclone therapy

Ono updates latest pipeline developments

Antitumor activity and improved toxicity of new agent to target and suppress survivin

New SK inhibitors: candidates for hyperproliferative, inflammatory and angiogenic diseases

PEP-005 Topical produces statistically significant complete clearance of AK skin lesions in phase II

LY-156735 reduces body weight, without altering food consumption

Adherex Technologies gets IND clearance for eniluracil trials

BioDelivery Sciences International plans trials for BEMA Long Acting Analgesic

Y's advances YSPSL into phase II for prevention of delayed graft function

Enrollment completed in phase III study of CellCept for myasthenia gravis

Phase II maribavir study completes enrollment

One-year trial data show fewer liver function abnormalities with sitaxsentan

European filing for bifeprunox delayed until 2008

SuppreMol launched as new company

AAGP protects skin cells from ultra violet-C radiation

XACT trial of AMD-070 now enrolling HIV patients

Vitae begins phase II study for VTP-201227 in psoriasis

Phase II trial assesses VTP-195183 in combination with G-CSF

Acambis begins phase I trial for C. difficile vaccine

New orally active MetAP2 inhibitor with promising in vivo antitumor activity

BioInvent's antibody candidate for atherosclerosis

Paliperidone ER submitted for FDA approval in schizophrenia

Korean approval for udenafil in erectile dysfunction

Polyphenon E Ointment NDA accepted for review

Spectrum selective kinase inhibitors from Exelixis evaluated in phase I trials

Phase I results encourage further investigation of SNS-595

Pfizer patents disclose compounds with potential for HIV and AIDS

Recent patents describe novel agents for metabolic disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...